Our Research

Science to serve one goal: Better health

Scientists at Group Health Research Institute (GHRI) have a rare advantage: We work within a system that provides both care and coverage. With a 360-degree view of people’s everyday health experience over time, we discover what works best to serve Group Health’s mission: Better health.  

We collaborate closely with Group Health’s medical staff and other providers—gaining from their perspectives on practical approaches to health care’s toughest problems.  Together, we create a learning health care system—a place where research strengthens practice and practice strengthen research.


Scientists

Working in the public interest

Our faculty members work on interdisciplinary research teams, conducting about 300 studies at any given time. We collaborate with affiliate researchers and others from leading academic institutions and health systems. Our clinical associates help facilitate work within Group Health's own care-delivery system and health plan.

We share our findings freely in the public domain, so that health care organizations everywhere can use our research to serve the public good. 

See our GHRI researcher directory

Funding sources

A broad base of support

Most of our support comes from federal agencies, such as the National Institutes of Health.  We also contract with biomedical companies and receive grants from private foundations, including the Group Health Foundation.  About 5 percent of our budget comes from Group Health.  

See our list of funders. 

Recent publications

Leveraging biospecimen resources for discovery or validation of markers for early cancer detection.

Schully SD, Carrick DM, Mechanic LE, Srivastava S, Anderson GL, Baron JA, Berg CD, Cullen J, Diamandis EP, Doria-Rose VP, Goddard KA, Hankinson SE, Kushi LH, Larson EB, McShane LM, Schilsky RL, Shak S, Skates SJ, Urban N, Kramer BS, Khoury MJ, Ransohoff DF.

J Natl Cancer Inst. 2015 Feb 16;107(4). pii: djv012. doi: 10.1093/jnci/djv012. Print 2015. PubMed

Prognostic significance of mammographic density change after initiation of tamoxifen for ER-positive breast cancer.

Nyante SJ, Sherman ME, Pfeiffer RM, Berrington de Gonzalez A, Brinton LA, Aiello Bowles EJ, Hoover RN, Glass A, Gierach GL.

J Natl Cancer Inst. 2015 Feb 6;107(3). pii: dju425. doi: 10.1093/jnci/dju425. Print 2015. PubMed


Collaborate with us

GHRI oversees all research conducted at Group Health, ensuring that all studies involving Group Health members are aligned with the organization’s primary mission: to improve health.  Researchers from outside Group Health can learn more about our processes for collaborating with GHRI faculty members.